Ann Marie Madera

USPTO Granted Patents = 14 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 37(Granted Patents)

Company Filing History:

Years Active: 2002-2018

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10029994 - Isoxazole hydroxamic acid compounds as LpxC inhibitors (2018-07-24),

2. 9815804 - Isoxazole hydroxamic acid compounds as LpxC inhibitors (2017-11-14),

3. 9549916 - Isoxazole hydroxamic acid compounds as LpxC inhibitors (2017-01-24),

4. 8513425 - Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof (2013-08-20),

5. 8084623 - Pyrrolidinyl and piperidinyl ketone derivatives and uses thereof (2011-12-27),

6. 7381739 - 2,4-substituted indoles and methods of use (2008-06-03),

7. 7247651 - 2,7-substituted indoles (2007-07-24),

8. 6864266 - 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists (2005-03-08),

9. 6818645 - Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists (2004-11-16),

10. 6806278 - Amino-tetralin derivatives as muscarinic receptor antagonists (2004-10-19),

11. 6645958 - Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists (2003-11-11),

12. 6635658 - Amino-tetralin derivatives as muscarinic receptor antagonists (2003-10-21),

13. 6627644 - 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists (2003-09-30),

14. 6500822 - Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists (2002-12-31),

Title: Unveiling the Inventive Spirit of Ann Marie Madera

Introduction:

Ann Marie Madera, a prolific inventor based in Dublin, California (US), has carved a niche for herself in the realm of innovation. With an impressive track record and a keen eye for addressing critical issues, Madera has made significant contributions to the field of medicine through her patented inventions.

Latest Patents:

Among her 14 patents, one of the most recent breakthroughs by Madera is the development of Isoxazole hydroxamic acid compounds as LpxC inhibitors. This pioneering invention introduces compounds of Formula I that show promise in treating bacterial infections, particularly those caused by Gram-negative bacteria. The compositions derived from these compounds offer innovative methods for combating infections effectively.

Career Highlights:

Throughout her career, Madera has honed her expertise while working with esteemed companies such as Syntex (USA) Inc. and Roche Palo Alto LLC. Her dedication to advancing medical solutions has led to the creation of groundbreaking patents that have the potential to revolutionize the healthcare industry.

Collaborations:

Madera's innovative drive is further fueled by collaborations with accomplished professionals in the field. Notable coworkers like Robert James Weikert and Jiping Fu have contributed to the success of her projects, underscoring the importance of teamwork in achieving groundbreaking results.

Conclusion:

Ann Marie Madera's exceptional work ethic, combined with her ingenuity and collaborative spirit, sets her apart as a trailblazing inventor in the competitive landscape of medical innovations. Her relentless pursuit of novel solutions reflects a deep commitment to improving healthcare outcomes, making her a respected figure in the realm of inventions and patents.

This text is generated by artificial intelligence and may not be accurate.